Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based...

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Cancer remains a leading cause of death with increasing mortality predictions.
• Conventional cancer therapies face limitations including lack of selectivity, non-specific distribution, and multidrug resistance.
• Novel strategies are crucial to improve chemotherapeutic agent efficiency and overcome treatment challenges.

Purpose of the Study:

• To analyze synergistic anticancer outcomes from combined therapy using natural compounds with chemotherapeutics or nucleic acids.
• To highlight the importance of co-delivery strategies in nanocarriers for enhancing therapeutic potential.
• To discuss the role of these strategies in reducing multidrug resistance and adverse toxic effects.

Main Methods:

• Review of existing literature on combined natural compounds and chemotherapeutics/nucleic acids.
• Analysis of co-delivery systems, particularly lipid-based nanocarriers.
• Evaluation of synergistic anticancer effects and mechanisms.

Main Results:

• Combined therapy demonstrates synergistic anticancer effects, improving treatment outcomes.
• Co-delivery in nanocarriers enhances the efficacy of combined therapeutic agents.
• Strategies effectively reduce multidrug resistance and mitigate adverse toxic effects associated with conventional treatments.

Conclusions:

• Co-delivery of natural compounds with chemotherapeutics or nucleic acids via nanocarriers is a promising strategy for improved cancer treatment.
• This approach offers significant advantages in overcoming treatment limitations and enhancing patient outcomes.
• Further research and development are needed for successful clinical translation of these co-delivery strategies.